How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?

Background. Direct-acting antivirals (DAAs) against hepatitis C virus (HCV) have been described as revolutionary. However, it remains uncertain how effective these drugs will be for individuals coinfected with human immunodeficiency virus (HIV)–HCV. Bridging this gap between efficacy and effectivene...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Saeed, Sahar, Strumpf, Erin C., Walmsley, Sharon L., Rollet-Kurhajec, Kathleen, Pick, Neora, Martel-Laferrière, Valerie, Hull, Mark, Gill, M. John, Cox, Joseph, Cooper, Curtis, Klein, Marina B.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
HIV/AIDS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4787608/
https://ncbi.nlm.nih.gov/pubmed/26743093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ1222
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars